KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Amortization of Deferred Charges (2016 - 2025)

Neogenomics filings provide 15 years of Amortization of Deferred Charges readings, the most recent being $9000.0 for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 81.25% to $9000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $87000.0, a 53.97% decrease, with the full-year FY2025 number at $87000.0, down 53.97% from a year prior.
  • Amortization of Deferred Charges hit $9000.0 in Q4 2025 for Neogenomics, roughly flat from $9000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $48000.0 in Q4 2024 to a low of $9000.0 in Q3 2025.
  • Median Amortization of Deferred Charges over the past 5 years was $46000.0 (2022), compared with a mean of $41050.0.
  • Biggest five-year swings in Amortization of Deferred Charges: soared 73.08% in 2021 and later crashed 81.25% in 2025.
  • Neogenomics' Amortization of Deferred Charges stood at $45000.0 in 2021, then rose by 2.22% to $46000.0 in 2022, then changed by 0.0% to $46000.0 in 2023, then increased by 4.35% to $48000.0 in 2024, then crashed by 81.25% to $9000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $9000.0 (Q4 2025), $9000.0 (Q3 2025), and $21000.0 (Q2 2025) per Business Quant data.